Publicações

Pembrolizumab (Pembro) for Recurrent Head and Neck Squamous Cell Carcinoma (Hnscc): Post Hoc Analyses of Phase 3 Keynote-040 Prior Radiation Treatment (Rt) and Disease State.

AuthID
P-00R-4A9

Author(s)

Harrington, KJ

Cohen, EEW

Soulieres, D

Dinis, J

Licitra, LF

Ahn, MJ

Soria, A

Machiels, JPH

Mach, N

Mehra, R

Burtness, B

Lin, JX

Cheng, JD

Swaby, RF

Le Tourneau, C

Tipo de Documento

Abstract

Year published

2019

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 37, Número: 15

Conference

Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 31-JUN 04, 2019, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1200/jco.2019.37.15_suppl.6026

Wos: WOS:000487345805610

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Pembrolizumab (Pembro) for Recurrent Head and Neck Squamous Cell Carcinoma (Hnscc): Post Hoc Analyses of Phase 3 Keynote-040 Prior Radiation Treatment (Rt) and Disease State.

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Pembrolizumab (Pembro) for Recurrent Head and Neck Squamous Cell Carcinoma (Hnscc): Post Hoc Analyses of Phase 3 Keynote-040 Prior Radiation Treatment (Rt) and Disease State.

Links Úteis

Ajuda